Wayland Group Closes Transaction with ICC International Cannabis Corp.

May 30, 19

TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has completed a transaction relating to the sale of a 49.9% interest in Maricann B.V. (“Wayland International”), to ICC International Cannabis Corp. (CSE:WRLD.u) (FW8:8K51) (OTC:KNHBF) (“ICC”) pursuant to the terms of

Read More

Wayland Addresses Transaction with ICC International Cannabis Corp.

May 02, 19

TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) confirms that any failure-to-file cease trade order (“FFCTO”) derived from the Company’s delay in annual filings will not materially affect the Company’s sale of a 49.9% interest in its international asset and license portfolio to ICC International Cannabis

Read More

Wayland Group Confirms Delay in Annual Filings; Expects Issuance of Cease Trade Order

April 30, 19

TORONTO, ON, April 30, 2019 – Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that it will be delayed in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”)

Read More

Wayland Group Announces Anticipated Delay in Annual Filings

April 23, 19

TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that it anticipates a delay in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required

Read More

Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business

April 23, 19

TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (FW8:8K51) (OTC:WLDCF) (“ICC”). The terms of the definitive agreement

Read More

Wayland Provides Clarification on Recent German Tender Update

April 19, 19

TORONTO, April 18, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to expand on the update that the Company provided to the market on April 17, 2019 with respect to the ongoing process for domestic cultivation of medical cannabis in Germany (“the Update”). The Company would like

Read More

Wayland Provides Update on German Tender Process

April 17, 19

TORONTO, ON, April 17, 2019 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Earlier today, the German Federal Institute for Drugs and Medical Devices (“BfArM”) announced that 9 of the 13 cultivation

Read More

Wayland Group Announces Facility Drawdown

April 15, 19

TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the fifth facility under its previously-announced subscription agreement with Alpha Blue and has issued the corresponding Convertible Debenture and Facility Warrants. Please refer to the Company’s news release of

Read More

Wayland Group Announces Changes to the Board of Directors

April 10, 19

TORONTO, ON, April 9, 2019 – Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announces the following change to its Board of Directors. Due to personal reasons, Rudi Hilti has resigned as Director of Wayland Group Corp. Mr. Hilti’s responsibilities at his own commercial and non-commercial enterprises have increased to a level

Read More

Wayland Selected as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany

April 04, 19

TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is excited to announce that the Company has been selected by the German Federal Institute for Drugs and Medical Devices (“BfArM”), through its German joint venture DEMECAN GmbH, to begin domestic production of medical cannabis for the rapidly

Read More